Faster global financial news!
Pharmaceuticals
-
Vertex Pharmaceuticals Incorporated(VRTX) Q3: EPS 4.76 USD (below forecast), Revenue 3.44B USD (above forecast)
Vertex Pharmaceuticals Incorporated(VRTX) Q3 EPS: 4.76 USD; Forecast 4.82 USD Revenue: 3.44B USD; Forecast 3.42B USD Reporting period: 2026 Q3 (period ended 2026-09-30) Release date: 2026-11-02
-
Yahoo Finance analysis recommends Regeneron Pharmaceuticals (REGN) over Novo Nordisk (NVO) for 2026, citing strong recent performance across all major drugs.
The analysis highlights Regeneron's robust Q2 2026 performance, with record sales for Dupixent, EYLEA HD, and Libtayo, and a significant beat on earnings estimates. The company also expanded its pipel
-
Twist Bioscience (TWST) shares rose after Artisan Mid Cap Fund cited the company's growth in DNA demand driven by AI and pharmaceuticals.
Twist Bioscience (TWST) shares rose after Artisan Mid Cap Fund named it a significant contributor in its Q2 investor letter, noting the company benefits from the growing demand for DNA synthesis and d
-
Antipodes Global Value Strategy Fund divested from Sanofi (SNY) in Q2 2026 due to the underperformance of its R&D pipeline.
Investment firm Antipodes Global Value Strategy disclosed in its Q2 2026 letter to investors that it has exited its position in French pharmaceutical and healthcare company Sanofi (Nasdaq: SNY). The s
-
Vertex Pharmaceuticals Incorporated(VRTX) Q3: EPS 4.76 USD (below forecast), Revenue 3.44B USD (above forecast)
Vertex Pharmaceuticals Incorporated(VRTX) Q3 EPS: 4.76 USD; Forecast 4.82 USD Revenue: 3.44B USD; Forecast 3.42B USD Reporting period: 2026 Q3 (period ended 2026-09-30) Release date: 2026-11-02
-
Yahoo Finance analysis recommends Regeneron Pharmaceuticals (REGN) over Novo Nordisk (NVO) for 2026, citing strong recent performance across all major drugs.
The analysis highlights Regeneron's robust Q2 2026 performance, with record sales for Dupixent, EYLEA HD, and Libtayo, and a significant beat on earnings estimates. The company also expanded its pipel
-
Twist Bioscience (TWST) shares rose after Artisan Mid Cap Fund cited the company's growth in DNA demand driven by AI and pharmaceuticals.
Twist Bioscience (TWST) shares rose after Artisan Mid Cap Fund named it a significant contributor in its Q2 investor letter, noting the company benefits from the growing demand for DNA synthesis and d
-
Antipodes Global Value Strategy Fund divested from Sanofi (SNY) in Q2 2026 due to the underperformance of its R&D pipeline.
Investment firm Antipodes Global Value Strategy disclosed in its Q2 2026 letter to investors that it has exited its position in French pharmaceutical and healthcare company Sanofi (Nasdaq: SNY). The s
- No data
Pharmaceuticals
24H Trending
-
1
ETH (Ethereum) surged 5.31% in 1 hour, currently trading at $2,439.61
-
2
What Elements Are Included in Tokenomics? How to Use It to Identify Valuable Digital Currencies
-
3
Why are various blockchain protocols launching native stablecoins?
-
4
How to buy and sell HERO? First distinguish the project, then check the listing channels
-
5
Cosmos (ATOM) Outlook Analysis: Tokenomics Restructuring and Cross-Chain Upgrades
-
6
CVS Health plans to split into two independent publicly traded companies by early 2028, reversing its $78 billion acquisition of Aetna.
-
7
Where to Find Reliable USDT Trading Software: Top Exchange References and Selection Criteria
-
8
What is DAFI Token? A Comprehensive Guide to DAFI Protocol and Synthetic Token Mechanics
-
9
Why 1WO Price Predictions Are Unreliable: Current Status and Liquidity Analysis of 1World Online
-
10
Current Status and Future Outlook of IMX in Blockchain Gaming
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
